安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- HCV Guidance - Recommendations for Testing, Managing, and Treating . . .
Latest Update to the Guidance: March, 2025 The new Hepatitis C Point of Care Test and Treat Algorithm was made available for download
- Initial Treatment of Adults with HCV Infection – HCV Guidance
Initial treatment of HCV infection includes patients with chronic hepatitis C who have not been previously treated with interferon, peginterferon, ribavirin, or any HCV direct-acting antiviral (DAA) agent, whether investigational, or US Food and Drug Administration (FDA) approved
- Simplified HCV Treatment* for Treatment-Naive Adults Without Cirrhosis
Patients who have any of the following characteristics: Prior hepatitis C treatment Cirrhosis (see simplified treatment for treatment-naive adults with compensated cirrhosis) HBsAg positive Current pregnancy Known or suspected hepatocellular carcinoma Prior liver transplantation (see Resource Library for treatment recommendations for these
- Simplified HCV Treatment Algorithm for Treatment-Naive Adults With . . .
Who Is Eligible for Simplified Treatment Adults with chronic hepatitis C (any genotype) who have compensated cirrhosis (Child-Pugh A) and have not previously received hepatitis C treatment Liver biopsy is not required For the purpose of this guidance, a patient is presumed to have cirrhosis if they have a FIB-4 score >3 25 or any of the following findings from a previously performed test
- Hepatitis C Test and Treat Initial Visit
This discussion should encompass shared decision-making with consideration of patient wishes, provider comfort level managing potential HCV HBV coinfection, access to HBV therapy and treatment services, predicated ability to reach patient patient follow-up, and the overall risk of underlying HBV infection and risk of HBV flare reactivation
- HCV Guidance: Recommendations for Testing, Managing, and Treating . . .
The AASLD IDSA guidance on hepatitis C addresses management issues ranging from testing and linkage to care, the crucial first steps toward improving health outcomes for HCV-infected persons, to the optimal treatment regimen in particular patient situations Recommendations are evidence based and rapidly updated as new data from peer-reviewed research become available For each treatment
- Table of Contents - HCV Guidance
Welcome and Methods Introduction Methods Table 1 Summary of the Process and Methods for the Guidance Development Table 2 Rating System Used to Rate Level of Evidence and Strength of Recommendation Table 3 Commonly Used Abbreviations Test, Evaluate, Monitor Testing, Evaluation, and Monitoring of Hepatitis C HCV Testing and Linkage…
- Initial Treatment of Adults with HCV Infection
Initial treatment of HCV infection includes patients with chronic hepatitis C who have not been previously treated with interferon, peginterferon, ribavirin, or any HCV direct-acting antiviral (DAA) agent, whether investigational, or US Food and Drug Administration (FDA) approved
|
|
|